Publications by authors named "Willy Tonui"

Claim this Profile
P
Post-release monitoring pathway for the deployment of gene drive-modified mosquitoes for malaria control in Africa.
Dorington O Ogoyi, Julia Njagi, Willy Tonui, Brinda Dass, Hector Quemada

Malar J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for environmental risk assessment of gene drive applications for malaria vector control.
John B Connolly, John D Mumford, Debora C M Glandorf, Sarah Hartley, Owen T Lewis, Willy Tonui

Malar J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-Sectional Survey of Biosafety Professionals Regarding Genetically Modified Insects.
David A O'Brochta, Willy K Tonui, Brinda Dass, Stephanie James

Appl Biosaf· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major.
Peter Ngure, Zipporah Ng'ang'a, Albert Kimutai, Stella Kepha, Samuel Mong'are, Willy Tonui

Pan Afr Med J· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of the extracts of Tagetes minuta Linnaeus (Asteraceae), Acalypha fruticosa Forssk (Euphorbiaceae) and Tarchonanthus camphoratus L. (Compositae) against Phlebotomus duboscqi Neveu Lemaire (Diptera: Psychodidae), the vector for Leishmania major Yakimoff and Schokhor.
Laban N Ireri, Jedida Kongoro, Peter Ngure, Charles Mutai, Bernard Langat, Willy Tonui

J Vector Borne Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of Warburgia ugandensis, Psiadia punctulata and Chasmanthera dependens on Leishmania major promastigotes.
Edward K Githinji, Lucy W Irungu, Willy K Tonui, Geoffrey M Rukunga, Charles Mutai

Afr J Tradit Complement Altern Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya.
Elizabeth V M Kigondu, Geoffrey M Rukunga, Joseph M Keriko, Willy K Tonui, Jeremiah W Gathirwa

J Ethnopharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo efficacy of oral and intraperitoneal administration of extracts of Warburgia ugandensis (Canellaceae) in experimental treatment of Old World cutaneous leishmaniasis caused by Leishmania major.
Peter Kamau Ngure, Zipporah Ng'ang'a, Johnstone Ingonga, Geoffrey Rukunga, Willy Kiprotich Tonui

Afr J Tradit Complement Altern Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Situational analysis of leishmaniases research in Kenya.
Willy Kiprotich Tonui

Afr J Health Sci· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-pronged approach in leishmaniasis drug development in Kenya Medical Research Institute.
Robert M Karanja, Willy K Tonui

Afr J Health Sci· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
Mohammad A Al-Wabel, Willy K Tonui, Liwang Cui, Samuel K Martin, Richard G Titus

Am J Trop Med Hyg· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
Willy K Tonui, Richard G Titus

Am J Trop Med Hyg· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmania major soluble exo-antigens (LmSEAgs) protect neonatal BALB/C mice from a subsequent challenge with L. major and stimulate cytokine production by Leishmania-naïve human peripheral blood mononuclear cells.
Willy K Tonui, Richard G Titust

J Parasitol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major.
Willy K Tonui, J Santiago Mejia, Lisa Hochberg, M Lamine Mbow, Jeffrey R Ryan

Infect Immun· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis